Ralph Fernandez, MD
Obstetrics & Gynecology · Lafayette, LANPI 1740365311
Payments from drug & device makers
Across 229 payments — averaging $20.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$741
- AbbVie$681
- Pfizer$344
- Sumitomo Pharma America, Inc.$329
- Mayne Pharma Commercial LLC$313
- Caldera Medical, Inc$260
- plus $2K from 32 others
What the payments were for
- Food & beverage$4,41993%
- Education$3207%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 31 | $741 |
| AbbVie | 39 | $681 |
| Pfizer | 22 | $344 |
| Sumitomo Pharma America, Inc. | 20 | $329 |
| Mayne Pharma Commercial LLC | 11 | $313 |
| Caldera Medical, Inc | 2 | $260 |
| Avion Pharmaceuticals | 12 | $208 |
| Exeltis, USA Inc. | 11 | $175 |
| Bayer | 7 | $125 |
| Hologic Sales And Service, LLC | 6 | $121 |
| Johnson & Johnson | 2 | $117 |
| Daiichi Sankyo Inc. | 5 | $99 |
| Organon | 6 | $97 |
| Coopersurgical, Inc. | 3 | $91 |
| Axsome Therapeutics, Inc. | 5 | $89 |
| Amgen | 6 | $86 |
| Applied Medical Resources Corporation | 1 | $80 |
| Axonics, Inc. | 1 | $79 |
| Millicent US Inc | 4 | $79 |
| Sage Therapeutics, LLC | 3 | $63 |
| Pacira Pharmaceuticals Incorporated | 3 | $62 |
| Coloplast | 3 | $58 |
| Evofem Biosciences, Inc. | 3 | $57 |
| Myovant Sciences Inc. | 3 | $47 |
| BD | 2 | $44 |
| Vertical Pharmaceuticals, LLC | 2 | $37 |
| Bausch Health US, LLC | 2 | $36 |
| Mylan Pharmaceuticals Inc. | 3 | $35 |
| Currax Pharmaceuticals LLC | 2 | $34 |
| Radius Health, Inc. | 1 | $31 |
| Covidien LP | 1 | $24 |
| Biogen | 1 | $16 |
| Boston Scientific | 1 | $15 |
| Mycovia Pharmaceuticals, Inc. | 1 | $15 |
| Merck | 1 | $15 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $13 |
| Lupin Inc. | 1 | $13 |
| AMAG Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Desara$191
How this compares
$4,739 in reported general payments places this provider in the 85th percentile of 608 obstetrics & gynecology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 33 | $15,018 |
| Estradiol | 195 | $6,794 |
| LinzessLinaclotide | 11 | $5,863 |
| Solifenacin Succinate | 91 | $2,042 |
| ProgesteroneProgesterone, Micronized | 100 | $1,626 |
| Clindamycin Phosphate | 17 | $879 |
| Raloxifene Hcl | 50 | $762 |
| ValacyclovirValacyclovir Hcl | 14 | $727 |
| Ibandronate Sodium | 20 | $528 |
| Oxybutynin Chloride ErOxybutynin Chloride | 13 | $475 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 31 | $292 |
| Escitalopram Oxalate | 18 | $219 |
| Norethindrone Acetate | 14 | $206 |
| Clobetasol Propionate | 11 | $204 |
| Levothyroxine Sodium | 28 | $179 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $741 | $15,01833 claims |
| AbbVieLinzess | $681 | $5,86311 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 608 obstetrics & gynecology providers in Louisiana.
Other obstetrics & gynecology in Lafayette
- Russell PhelpsLafayette$31K
- Rachelle MeauxLafayette$31K
- Amanda AlleynLafayette$15K
- Jennifer PuglieseLafayette$14K
- Nicole HarperLafayette$13K
- Mika KingLafayette$9K
- Francis CardinaleLafayette$9K
- John VoltzLafayette$7K
- Alison RodriguezNew Orleans$10.5M
- Scott StriplinCovington$6.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.